Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wobenzym mono for acute rhinosinusitis
2007-002995-33Phase 2Terminated
- Sponsor
- Mucos Pharma
- Start
- Jul 2007
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bromelain in acute rhinosinusitis (ARS) (4 arms), sponsored by Mucos Pharma. Primary endpoint: Primary rhinosinusitis symptom score change. Started Jul 2007; status: terminated.
02
Drugs
bromelain
03
Conditions
acute rhinosinusitis (ARS)
Beyond the preview
Go deeper on 2007-002995-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002995-33.